To investigate the influence of KIR and HLA genes on the risk of HBV-associated HCC development, a case-control study was conducted in HBV-infected patients with HCC and well-matched HBV-infected patients without HCC as non-HCC controls. This evidence concerns the gene KIR3DL1 and hepatocellular carcinoma.